MarkWide Research

Sale!

Sleep Aids Market Analysis- Industry Size, Share, Research Report, Insights, Covid-19 Impact, Statistics, Trends, Growth and Forecast 2022-2030

Published Date: July, 2022
No of Pages: 160
Delivery Format: PDF + Excel

$2,950.00

The global sleep aids market was valued at $59815.10 million in 2020. It is expected to grow to $111,920.10 million by 2030. This will represent a 6.9% CAGR from 2021 to 2030. These conditions can affect the sleep pattern and disrupt restful sleep. They can also cause daytime sleepiness. You may experience frequent sleep problems, fatigue, or reduced or impaired ability for daytime activities. Insufficient sleep can lead to poor school and work performance, decreased interpersonal relationships, thoughts, mental health, weight, and increased diabetes and heart disease risk.

Sleep disorders such as insomnia, restless legs syndrome and sleep apnea are common. You can treat sleep disorders with medications and supplements such as counselling, medication & supplements such as zolpidem and zaleplon. Sleep impairment can also be treated with regular exercise and the proper management of temperature, light, and noise at the location. Sleep aids can also be used to treat sleep disorders.

The benefits of sleep aids products and the rise in disposable income are the main drivers of the market for sleep aids. The rise in obesity and geriatrics has increased sleep disorder cases. This will contribute to the growth of this market. The market growth in sleep aids is expected to be limited by the adverse effects of sleeping aids medication on the human body and many expired patents. The advancement of sleep aids products helps to increase their adoption and opens up new markets in developing countries, which will provide lucrative opportunities for market growth.

The Impact of Covid-19 on the Sleep Aids Market (Pre and Post Analysis)

Coronavirus (COVID-19), was first discovered in China’s Hubei province, Wuhan city. This virus is known as severe acute respiratory syndrome coronavirus 2 or SARS-CoV-2 and is transmitted between humans. The outlook for the sleep aids sector has significantly changed since the first COVID-19 outbreak. The COVID-19 pandemic caused a global lockdown that resulted in a reduction in trade in a variety of products, including sleep aids. The market suffered as a result of the lower demand for sleeping aids. The number of sleep aids products was also affected by the lower monthly incomes of people and the closure of factories to protect workers in all regions. Products were also affected by limited goods handling capacities at ports and financial distress. People feared the infection after a time of lockdown and distancing. Different regions reported a decrease in hospital visits.

Overall, COVID-19 harmed the market for sleep aids. This was due to a decrease in the demand for sleeping aids devices. Market players have also reduced their investment in raw materials and other resources due to the closure of all manufacturing plants to protect workers in all regions.

Segmentation of the sleep aids market can be based on product, sleep disorder, or region. The market can be divided by-products into mattresses & pillows and sleep laboratories. The medication segment can be divided into over-the-counter (OTC), prescription-based, and non-prescription drugs. It is classified into sleep disorders such as sleep apnea and restless leg syndrome, insomnia, sleepwalking, and other sleep disorders. The market for sleep aids is analyzed by region in North America, Europe and Asia-Pacific, and LAMEA.

Product segment review

The global market for sleep aids can be divided into three segments: mattresses & pillows (byproduct), sleep laboratories, medications, and rest apnea devices (byproduct). The global mattress & pillows market was the largest contributor in 2020. It is expected to continue to dominate in the forecast period because of technological advances in sleep aid devices, increased adoption of sleep aids, a rise in insomnia incidence, and an increased number of innovative and effective product launches.

Sleep Disorders segment review

The global market for sleep aids can be divided into sleep disorders. These include sleep apnea and restless leg syndrome, insomnia, restless leg syndromes, narcolepsy and sleepwalking. The insomnia segment led the global sleep aids market in 2020. It is expected to dominate in the forecast period due to increased healthcare awareness, sleep apnea incidence, decreased physical exercise, and a growing senior population.

Region Segment Review

North America held a major share of the global sleep aids market in 2020 and will remain the dominant region throughout the forecast period. This can be attributed to an increase in sleep disorders like sleep apnea and a surge in demand for sleeping aids, the availability of advanced healthcare facilities with trained professionals, the rise of R&D activities, the large presence of key players, as well as a surge in government investment in the healthcare system. The fastest growth rate is expected in Asia-Pacific during the forecast period. Japan and China will also experience a high CAGR in Asia-Pacific’s sleep aid market. This is due to improvements in healthcare infrastructure, an increased number of hospitals with advanced instruments, the R&D sector and technological advances in sleep aids.

Sleep Aids Market Report Scope and Segmentation

ATTRIBUTESDETAILS
ESTIMATED YEAR2022
BASE YEAR2021
FORECAST YEAR2030
HISTORICAL YEAR2017-2021
UNITValue (USD Million/Billion)
BY REGIONNorth America, Europe, Asia Pacific, Latin America, Middle East and Africa

Benefits for stakeholders

  • This report presents a quantitative analysis of current market trends in sleep aids and forecast estimates for 2021 to 2030. It helps identify market opportunities.
  • The in-depth market analysis includes an analysis of different regions. This will provide stakeholders with a comprehensive understanding of current trends and enable them to formulate regional-specific plans.
  • This report provides a comprehensive analysis of the factors that have influenced and resisted the growth of the global sleep aids market.
  • This report is based on a study of the future market trends and potential value for 2020 to 2030.
  • Companies can use the insights from a thorough analysis of different regions to strategically plan their business moves.
  • This report profiles key market players in the sleep aids market and analyzes their strategies thoroughly. This helps to understand the market’s competitive outlook.

Key Market Segments

  • By PRODUCT
    • Mattresses & Pillows
    • Sleep Laboratories
  • Medications
      • Prescription-Based Drugs
    • OTC Drugs
    • Sleep Apnea Equipment
  • By SLEEP DISORDERS
    • Insomnia
    • Sleep Apnea
    • Restless Leg Syndrome
    • Narcolepsy
    • Sleepwalking
    • Other Sleep Disorders
  • By REGION
    • North America
      • US
      • Canada
      • Mexico
    • Europe
      • Germany
      • Italy
      • France
      • UK
      • Spain
      • Poland
      • Russia
      • The Netherlands
      • Norway
      • Czech Republic
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • South Korea
      • Indonesia
      • Malaysia
      • Thailand
      • Singapore
      • Australia & New Zealand
      • Rest of Asia Pacific
    • South America
      • Brazil
      • Argentina
      • Colombia
      • Rest of South America
    • The Middle East & Africa
      • Saudi Arabia
      • UAE
      • South Africa
      • Northern Africa
      • Rest of MEA
  • KEY MARKET PLAYERS
    • Cadwell Industries, Inc.
    • Compumedics Limited
    • Drive DeVilbiss Healthcare Inc.
    • GlaxoSmithKline Plc
    • Merck& Co., Inc.
    • Natus Medical Inc.
    • Koninklijke Philips N.V.
    • PFIZER, INC.
    • Sanofi S.A.
    • SleepMed Inc.

 

Table of Contents

CHAPTER 1:INTRODUCTION

1.1.Report Description
1.2.Key Market Segments
1.3.Key Benefits
1.4.Research Methodology
1.4.1.Primary Research
1.4.2.Secondary Research
1.4.3.Analyst Tools and Models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.CXO Perspective

CHAPTER 3:MARKET LANDSCAPE

3.1.Market Definition and Scope
3.2.Key Findings

3.2.1.Top Investment Pockets
3.2.2.Top Winning Strategies

3.3.Porter’s Five Forces Analysis

3.3.1.Bargaining Power of Suppliers
3.3.2.Threat of New Entrants
3.3.3.Threat of Substitutes
3.3.4.Competitive Rivalry
3.3.5.Bargaining Power among Buyers

3.4.Market Share Analysis Top Player Positioning

3.4.1.Market Share Analysis/Top Player Positioning 2020

3.5.Market Dynamics

3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities

3.6.COVID-19 Impact Analysis

CHAPTER 4:SLEEP AIDS MARKET, BY PRODUCT

4.1.Market Overview

4.1.1Market Size and Forecast, By Product

4.2.MATTRESSES & PILLOWS

4.2.1.Key Market Trends, Growth Factors and Opportunities
4.2.2.Market Size and Forecast, By Region
4.2.3.Market Share Analysis, By Country

4.3.SLEEP LABORATORIES

4.3.1.Key Market Trends, Growth Factors and Opportunities
4.3.2.Market Size and Forecast, By Region
4.3.3.Market Share Analysis, By Country

4.4.MEDICATIONS

4.4.1.Key Market Trends, Growth Factors and Opportunities
4.4.2.Market Size and Forecast, By Region
4.4.3.Market Share Analysis, By Country
4.4.4.Prescription-based drugs

4.4.4.1.Market Size and Forecast

4.4.5.OTC drugs

4.4.5.1.Market Size and Forecast

4.5.SLEEP APNEA DEVICES

4.5.1.Key Market Trends, Growth Factors and Opportunities
4.5.2.Market Size and Forecast, By Region
4.5.3.Market Share Analysis, By Country

CHAPTER 5:SLEEP AIDS MARKET, BY SLEEP DISORDERS

5.1.Market Overview

5.1.1Market Size and Forecast, By Sleep Disorders

5.2.INSOMNIA

5.2.1.Market Size and Forecast, By Region
5.2.2.Market Share Analysis, By Country

5.3.SLEEP APNEA

5.3.1.Market Size and Forecast, By Region
5.3.2.Market Share Analysis, By Country

5.4.RESTLESS LEGS SYNDROME

5.4.1.Market Size and Forecast, By Region
5.4.2.Market Share Analysis, By Country

5.5.NARCOLEPSY

5.5.1.Market Size and Forecast, By Region
5.5.2.Market Share Analysis, By Country

5.6.SLEEPWALKING

5.6.1.Market Size and Forecast, By Region
5.6.2.Market Share Analysis, By Country

5.7.OTHER SLEEP DISORDERS

5.7.1.Market Size and Forecast, By Region
5.7.2.Market Share Analysis, By Country

CHAPTER 6:SLEEP AIDS MARKET, BY REGION

6.1.Market Overview

6.1.1Market Size and Forecast, By Region

6.2.North America

6.2.1.Key Market Trends and Opportunities
6.2.2.Market Size and Forecast, By Product
6.2.3.Market Size and Forecast, By Sleep Disorders
6.2.4.Market Size and Forecast, By Country
6.2.5.United States Sleep Aids Market

6.2.5.1.Market Size and Forecast, By Product
6.2.5.2.Market Size and Forecast, By Sleep Disorders

6.2.6.Canada Sleep Aids Market

6.2.6.1.Market Size and Forecast, By Product
6.2.6.2.Market Size and Forecast, By Sleep Disorders

6.2.7.Mexico Sleep Aids Market

6.2.7.1.Market Size and Forecast, By Product
6.2.7.2.Market Size and Forecast, By Sleep Disorders

6.3.Europe

6.3.1.Key Market Trends and Opportunities
6.3.2.Market Size and Forecast, By Product
6.3.3.Market Size and Forecast, By Sleep Disorders
6.3.4.Market Size and Forecast, By Country
6.3.5.Germany Sleep Aids Market

6.3.5.1.Market Size and Forecast, By Product
6.3.5.2.Market Size and Forecast, By Sleep Disorders

6.3.6.France Sleep Aids Market

6.3.6.1.Market Size and Forecast, By Product
6.3.6.2.Market Size and Forecast, By Sleep Disorders

6.3.7.Uk Sleep Aids Market

6.3.7.1.Market Size and Forecast, By Product
6.3.7.2.Market Size and Forecast, By Sleep Disorders

6.3.8.Italy Sleep Aids Market

6.3.8.1.Market Size and Forecast, By Product
6.3.8.2.Market Size and Forecast, By Sleep Disorders

6.3.9.Spain Sleep Aids Market

6.3.9.1.Market Size and Forecast, By Product
6.3.9.2.Market Size and Forecast, By Sleep Disorders

6.3.10.Rest Of Europe Sleep Aids Market

6.3.10.1.Market Size and Forecast, By Product
6.3.10.2.Market Size and Forecast, By Sleep Disorders

6.4.Asia-Pacific

6.4.1.Key Market Trends and Opportunities
6.4.2.Market Size and Forecast, By Product
6.4.3.Market Size and Forecast, By Sleep Disorders
6.4.4.Market Size and Forecast, By Country
6.4.5.Japan Sleep Aids Market

6.4.5.1.Market Size and Forecast, By Product
6.4.5.2.Market Size and Forecast, By Sleep Disorders

6.4.6.China Sleep Aids Market

6.4.6.1.Market Size and Forecast, By Product
6.4.6.2.Market Size and Forecast, By Sleep Disorders

6.4.7.Australia Sleep Aids Market

6.4.7.1.Market Size and Forecast, By Product
6.4.7.2.Market Size and Forecast, By Sleep Disorders

6.4.8.India Sleep Aids Market

6.4.8.1.Market Size and Forecast, By Product
6.4.8.2.Market Size and Forecast, By Sleep Disorders

6.4.9.South Korea Sleep Aids Market

6.4.9.1.Market Size and Forecast, By Product
6.4.9.2.Market Size and Forecast, By Sleep Disorders

6.4.10.Rest Of Asia-pacific Sleep Aids Market

6.4.10.1.Market Size and Forecast, By Product
6.4.10.2.Market Size and Forecast, By Sleep Disorders

6.5.LAMEA

6.5.1.Key Market Trends and Opportunities
6.5.2.Market Size and Forecast, By Product
6.5.3.Market Size and Forecast, By Sleep Disorders
6.5.4.Market Size and Forecast, By Country
6.5.5.Brazil Sleep Aids Market

6.5.5.1.Market Size and Forecast, By Product
6.5.5.2.Market Size and Forecast, By Sleep Disorders

6.5.6.Saudi Arabia Sleep Aids Market

6.5.6.1.Market Size and Forecast, By Product
6.5.6.2.Market Size and Forecast, By Sleep Disorders

6.5.7.South Africa Sleep Aids Market

6.5.7.1.Market Size and Forecast, By Product
6.5.7.2.Market Size and Forecast, By Sleep Disorders

6.5.8.Rest of LAMEA Sleep Aids Market

6.5.8.1.Market Size and Forecast, By Product
6.5.8.2.Market Size and Forecast, By Sleep Disorders

CHAPTER 7:COMPANY PROFILES

7.1.Cadwell Industries, Inc.

7.1.1.Company Overview
7.1.2.Key Executives
7.1.3.Company snapshot
7.1.4.Operating business segments
7.1.5.Product portfolio
7.1.6.Business Performance
7.1.7.Key Strategic Moves and Developments

7.2.Compumedics Limited

7.2.1.Company Overview
7.2.2.Key Executives
7.2.3.Company snapshot
7.2.4.Operating business segments
7.2.5.Product portfolio
7.2.6.Business Performance
7.2.7.Key Strategic Moves and Developments

7.3.Drive DeVilbiss Healthcare Inc.

7.3.1.Company Overview
7.3.2.Key Executives
7.3.3.Company snapshot
7.3.4.Operating business segments
7.3.5.Product portfolio
7.3.6.Business Performance
7.3.7.Key Strategic Moves and Developments

7.4.GlaxoSmithKline Plc

7.4.1.Company Overview
7.4.2.Key Executives
7.4.3.Company snapshot
7.4.4.Operating business segments
7.4.5.Product portfolio
7.4.6.Business Performance
7.4.7.Key Strategic Moves and Developments

7.5.Merck And Co., Inc.

7.5.1.Company Overview
7.5.2.Key Executives
7.5.3.Company snapshot
7.5.4.Operating business segments
7.5.5.Product portfolio
7.5.6.Business Performance
7.5.7.Key Strategic Moves and Developments

7.6.Natus Medical Inc.

7.6.1.Company Overview
7.6.2.Key Executives
7.6.3.Company snapshot
7.6.4.Operating business segments
7.6.5.Product portfolio
7.6.6.Business Performance
7.6.7.Key Strategic Moves and Developments

7.7.Koninklijke Philips N.V.

7.7.1.Company Overview
7.7.2.Key Executives
7.7.3.Company snapshot
7.7.4.Operating business segments
7.7.5.Product portfolio
7.7.6.Business Performance
7.7.7.Key Strategic Moves and Developments

7.8.PFIZER, INC.

7.8.1.Company Overview
7.8.2.Key Executives
7.8.3.Company snapshot
7.8.4.Operating business segments
7.8.5.Product portfolio
7.8.6.Business Performance
7.8.7.Key Strategic Moves and Developments

7.9.Sanofi S.A.

7.9.1.Company Overview
7.9.2.Key Executives
7.9.3.Company snapshot
7.9.4.Operating business segments
7.9.5.Product portfolio
7.9.6.Business Performance
7.9.7.Key Strategic Moves and Developments

7.10.SleepMed Inc.

7.10.1.Company Overview
7.10.2.Key Executives
7.10.3.Company snapshot
7.10.4.Operating business segments
7.10.5.Product portfolio
7.10.6.Business Performance
7.10.7.Key Strategic Moves and Developments

LIST OF TABLES

TABLE 1.GLOBAL SLEEP AIDS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 2.GLOBAL SLEEP AIDS MARKET FOR MATTRESSES & PILLOWS, BY REGION, 2020-2030 ($MILLION)
TABLE 3.GLOBAL SLEEP AIDS MARKET FOR SLEEP LABORATORIES, BY REGION, 2020-2030 ($MILLION)
TABLE 4.GLOBAL SLEEP AIDS MARKET FOR MEDICATIONS, BY REGION, 2020-2030 ($MILLION)
TABLE 5.GLOBAL SLEEP AIDS MARKET FOR SLEEP APNEA DEVICES, BY REGION, 2020-2030 ($MILLION)
TABLE 6.GLOBAL SLEEP AIDS MARKET, BY SLEEP DISORDERS, 2020-2030 ($MILLION)
TABLE 7.GLOBAL SLEEP AIDS MARKET FOR INSOMNIA, BY REGION, 2020-2030 ($MILLION)
TABLE 8.GLOBAL SLEEP AIDS MARKET FOR SLEEP APNEA, BY REGION, 2020-2030 ($MILLION)
TABLE 9.GLOBAL SLEEP AIDS MARKET FOR RESTLESS LEGS SYNDROME, BY REGION, 2020-2030 ($MILLION)
TABLE 10.GLOBAL SLEEP AIDS MARKET FOR NARCOLEPSY, BY REGION, 2020-2030 ($MILLION)
TABLE 11.GLOBAL SLEEP AIDS MARKET FOR SLEEPWALKING, BY REGION, 2020-2030 ($MILLION)
TABLE 12.GLOBAL SLEEP AIDS MARKET FOR OTHER SLEEP DISORDERS, BY REGION, 2020-2030 ($MILLION)
TABLE 13.GLOBAL SLEEP AIDS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 14.NORTH AMERICA SLEEP AIDS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 15.NORTH AMERICA SLEEP AIDS, BY SLEEP DISORDERS, 2020-2030 ($MILLION)
TABLE 16.UNITED STATES SLEEP AIDS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 17.UNITED STATES SLEEP AIDS, BY SLEEP DISORDERS, 2020-2030 ($MILLION)
TABLE 18.CANADA SLEEP AIDS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 19.CANADA SLEEP AIDS, BY SLEEP DISORDERS, 2020-2030 ($MILLION)
TABLE 20.MEXICO SLEEP AIDS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 21.MEXICO SLEEP AIDS, BY SLEEP DISORDERS, 2020-2030 ($MILLION)
TABLE 22.EUROPE SLEEP AIDS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 23.EUROPE SLEEP AIDS, BY SLEEP DISORDERS, 2020-2030 ($MILLION)
TABLE 24.GERMANY SLEEP AIDS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 25.GERMANY SLEEP AIDS, BY SLEEP DISORDERS, 2020-2030 ($MILLION)
TABLE 26.FRANCE SLEEP AIDS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 27.FRANCE SLEEP AIDS, BY SLEEP DISORDERS, 2020-2030 ($MILLION)
TABLE 28.UK SLEEP AIDS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 29.UK SLEEP AIDS, BY SLEEP DISORDERS, 2020-2030 ($MILLION)
TABLE 30.ITALY SLEEP AIDS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 31.ITALY SLEEP AIDS, BY SLEEP DISORDERS, 2020-2030 ($MILLION)
TABLE 32.SPAIN SLEEP AIDS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 33.SPAIN SLEEP AIDS, BY SLEEP DISORDERS, 2020-2030 ($MILLION)
TABLE 34.REST OF EUROPE SLEEP AIDS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 35.REST OF EUROPE SLEEP AIDS, BY SLEEP DISORDERS, 2020-2030 ($MILLION)
TABLE 36.ASIA-PACIFIC SLEEP AIDS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 37.ASIA-PACIFIC SLEEP AIDS, BY SLEEP DISORDERS, 2020-2030 ($MILLION)
TABLE 38.JAPAN SLEEP AIDS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 39.JAPAN SLEEP AIDS, BY SLEEP DISORDERS, 2020-2030 ($MILLION)
TABLE 40.CHINA SLEEP AIDS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 41.CHINA SLEEP AIDS, BY SLEEP DISORDERS, 2020-2030 ($MILLION)
TABLE 42.AUSTRALIA SLEEP AIDS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 43.AUSTRALIA SLEEP AIDS, BY SLEEP DISORDERS, 2020-2030 ($MILLION)
TABLE 44.INDIA SLEEP AIDS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 45.INDIA SLEEP AIDS, BY SLEEP DISORDERS, 2020-2030 ($MILLION)
TABLE 46.SOUTH KOREA SLEEP AIDS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 47.SOUTH KOREA SLEEP AIDS, BY SLEEP DISORDERS, 2020-2030 ($MILLION)
TABLE 48.REST OF ASIA-PACIFIC SLEEP AIDS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 49.REST OF ASIA-PACIFIC SLEEP AIDS, BY SLEEP DISORDERS, 2020-2030 ($MILLION)
TABLE 50.LAMEA SLEEP AIDS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 51.LAMEA SLEEP AIDS, BY SLEEP DISORDERS, 2020-2030 ($MILLION)
TABLE 52.BRAZIL SLEEP AIDS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 53.BRAZIL SLEEP AIDS, BY SLEEP DISORDERS, 2020-2030 ($MILLION)
TABLE 54.SAUDI ARABIA SLEEP AIDS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 55.SAUDI ARABIA SLEEP AIDS, BY SLEEP DISORDERS, 2020-2030 ($MILLION)
TABLE 56.SOUTH AFRICA SLEEP AIDS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 57.SOUTH AFRICA SLEEP AIDS, BY SLEEP DISORDERS, 2020-2030 ($MILLION)
TABLE 58.REST OF LAMEA SLEEP AIDS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 59.REST OF LAMEA SLEEP AIDS, BY SLEEP DISORDERS, 2020-2030 ($MILLION)
TABLE 60.CADWELL INDUSTRIES, INC.: KEY EXECUTIVES
TABLE 61.CADWELL INDUSTRIES, INC.: COMPANY SNAPSHOT
TABLE 62.CADWELL INDUSTRIES, INC.: OPERATING SEGMENTS
TABLE 63.CADWELL INDUSTRIES, INC.: PRODUCT PORTFOLIO
TABLE 64.CADWELL INDUSTRIES, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 65.COMPUMEDICS LIMITED: KEY EXECUTIVES
TABLE 66.COMPUMEDICS LIMITED: COMPANY SNAPSHOT
TABLE 67.COMPUMEDICS LIMITED: OPERATING SEGMENTS
TABLE 68.COMPUMEDICS LIMITED: PRODUCT PORTFOLIO
TABLE 69.COMPUMEDICS LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 70.DRIVE DEVILBISS HEALTHCARE INC.: KEY EXECUTIVES
TABLE 71.DRIVE DEVILBISS HEALTHCARE INC.: COMPANY SNAPSHOT
TABLE 72.DRIVE DEVILBISS HEALTHCARE INC.: OPERATING SEGMENTS
TABLE 73.DRIVE DEVILBISS HEALTHCARE INC.: PRODUCT PORTFOLIO
TABLE 74.DRIVE DEVILBISS HEALTHCARE INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 75.GLAXOSMITHKLINE PLC: KEY EXECUTIVES
TABLE 76.GLAXOSMITHKLINE PLC: COMPANY SNAPSHOT
TABLE 77.GLAXOSMITHKLINE PLC: OPERATING SEGMENTS
TABLE 78.GLAXOSMITHKLINE PLC: PRODUCT PORTFOLIO
TABLE 79.GLAXOSMITHKLINE PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 80.MERCK AND CO., INC.: KEY EXECUTIVES
TABLE 81.MERCK AND CO., INC.: COMPANY SNAPSHOT
TABLE 82.MERCK AND CO., INC.: OPERATING SEGMENTS
TABLE 83.MERCK AND CO., INC.: PRODUCT PORTFOLIO
TABLE 84.MERCK AND CO., INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 85.NATUS MEDICAL INC.: KEY EXECUTIVES
TABLE 86.NATUS MEDICAL INC.: COMPANY SNAPSHOT
TABLE 87.NATUS MEDICAL INC.: OPERATING SEGMENTS
TABLE 88.NATUS MEDICAL INC.: PRODUCT PORTFOLIO
TABLE 89.NATUS MEDICAL INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 90.KONINKLIJKE PHILIPS N.V.: KEY EXECUTIVES
TABLE 91.KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
TABLE 92.KONINKLIJKE PHILIPS N.V.: OPERATING SEGMENTS
TABLE 93.KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
TABLE 94.KONINKLIJKE PHILIPS N.V.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 95.PFIZER, INC.: KEY EXECUTIVES
TABLE 96.PFIZER, INC.: COMPANY SNAPSHOT
TABLE 97.PFIZER, INC.: OPERATING SEGMENTS
TABLE 98.PFIZER, INC.: PRODUCT PORTFOLIO
TABLE 99.PFIZER, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 100.SANOFI S.A.: KEY EXECUTIVES
TABLE 101.SANOFI S.A.: COMPANY SNAPSHOT
TABLE 102.SANOFI S.A.: OPERATING SEGMENTS
TABLE 103.SANOFI S.A.: PRODUCT PORTFOLIO
TABLE 104.SANOFI S.A.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 105.SLEEPMED INC.: KEY EXECUTIVES
TABLE 106.SLEEPMED INC.: COMPANY SNAPSHOT
TABLE 107.SLEEPMED INC.: OPERATING SEGMENTS
TABLE 108.SLEEPMED INC.: PRODUCT PORTFOLIO
TABLE 109.SLEEPMED INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 1.GLOBAL SLEEP AIDS MARKET SEGMENTATION
FIGURE 2.GLOBAL SLEEP AIDS MARKET
FIGURE 3.SEGMENTATION SLEEP AIDS MARKET
FIGURE 4.TOP INVESTMENT POCKET IN SLEEP AIDS MARKET
FIGURE 5.TOP WINNING STRATEGIES, 2019-2021*
FIGURE 6.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019-2021(%)
FIGURE 7.TOP WINNING STRATEGIES, BY COMPANY, 2019-2021*
FIGURE 8.MODERATE BARGAINING POWER OF BUYERS
FIGURE 9.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 10.MODERATE THREAT OF NEW ENTRANTS
FIGURE 11.LOW THREAT OF SUBSTITUTION
FIGURE 12.HIGH COMPETITIVE RIVALRY
FIGURE 13.TOP PLAYER POSITIONING, 2020
FIGURE 14.MARKET SHARE ANALYSIS, 2020
FIGURE 15.RESTRAINTS AND DRIVERS: SLEEP AIDS MARKET
FIGURE 16.SLEEP AIDS MARKET SEGMENTATION, BY PRODUCT
FIGURE 17.SLEEP AIDS MARKET FOR MATTRESSES & PILLOWS, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 18.SLEEP AIDS MARKET FOR SLEEP LABORATORIES, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 19.SLEEP AIDS MARKET FOR MEDICATIONS, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 20.SLEEP AIDS MARKET FOR SLEEP APNEA DEVICES, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 21.SLEEP AIDS MARKET SEGMENTATION, BY SLEEP DISORDERS
FIGURE 22.SLEEP AIDS MARKET FOR INSOMNIA, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 23.SLEEP AIDS MARKET FOR SLEEP APNEA, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 24.SLEEP AIDS MARKET FOR RESTLESS LEGS SYNDROME, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 25.SLEEP AIDS MARKET FOR NARCOLEPSY, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 26.SLEEP AIDS MARKET FOR SLEEPWALKING, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 27.SLEEP AIDS MARKET FOR OTHER SLEEP DISORDERS, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 28.CADWELL INDUSTRIES, INC.: NET SALES, 2018-2020 ($MILLION)
FIGURE 29.CADWELL INDUSTRIES, INC.: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 30.CADWELL INDUSTRIES, INC.: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 31.COMPUMEDICS LIMITED: NET SALES, 2018-2020 ($MILLION)
FIGURE 32.COMPUMEDICS LIMITED: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 33.COMPUMEDICS LIMITED: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 34.DRIVE DEVILBISS HEALTHCARE INC.: NET SALES, 2018-2020 ($MILLION)
FIGURE 35.DRIVE DEVILBISS HEALTHCARE INC.: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 36.DRIVE DEVILBISS HEALTHCARE INC.: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 37.GLAXOSMITHKLINE PLC: NET SALES, 2018-2020 ($MILLION)
FIGURE 38.GLAXOSMITHKLINE PLC: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 39.GLAXOSMITHKLINE PLC: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 40.MERCK AND CO., INC.: NET SALES, 2018-2020 ($MILLION)
FIGURE 41.MERCK AND CO., INC.: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 42.MERCK AND CO., INC.: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 43.NATUS MEDICAL INC.: NET SALES, 2018-2020 ($MILLION)
FIGURE 44.NATUS MEDICAL INC.: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 45.NATUS MEDICAL INC.: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 46.KONINKLIJKE PHILIPS N.V.: NET SALES, 2018-2020 ($MILLION)
FIGURE 47.KONINKLIJKE PHILIPS N.V.: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 48.KONINKLIJKE PHILIPS N.V.: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 49.PFIZER, INC.: NET SALES, 2018-2020 ($MILLION)
FIGURE 50.PFIZER, INC.: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 51.PFIZER, INC.: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 52.SANOFI S.A.: NET SALES, 2018-2020 ($MILLION)
FIGURE 53.SANOFI S.A.: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 54.SANOFI S.A.: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 55.SLEEPMED INC.: NET SALES, 2018-2020 ($MILLION)
FIGURE 56.SLEEPMED INC.: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 57.SLEEPMED INC.: REVENUE SHARE, BY REGION, 2020 (%)

Major Companies

  • Cadwell Industries, Inc.
  • Compumedics Limited
  • Drive DeVilbiss Healthcare Inc.
  • GlaxoSmithKline Plc
  • Merck& Co., Inc.
  • Natus Medical Inc.
  • Koninklijke Philips N.V.
  • PFIZER, INC.
  • Sanofi S.A.
  • SleepMed Inc.
  • Others

Segmentation

  • By PRODUCT
    • Mattresses & Pillows
    • Sleep Laboratories
    • Medications
      • Prescription-Based Drugs
      • OTC Drugs
    • Sleep Apnea Devices
  • By SLEEP DISORDERS
    • Insomnia
    • Sleep Apnea
    • Restless Leg Syndrome
    • Narcolepsy
    • Sleepwalking
    • Other Sleep Disorders

Why Choose MWR

Quality Research

Our goal is to provide high-quality data that stimulates growth and creates a win-win situations

Unlimited User Access 

We offer Corporate User license access on all our reports in which you can share the report with your entire team without any restrictions

Free Company Inclusion 

We give you an option to include 3-4 additional company players of your choice in our report without any extra charges

Post Sale Assistance

Unlimited post sales service with an account manager dedicated to making sure that all your needs are met

Covid-19 Impact Analysis

All our research report includes latest Covid-19 Impact and its analysis

Download Free Sample PDF

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 424 360 2221

24/7 Customer Support

Download Free Sample PDF